| Withdrawn | Clinical Outcomes From Nalmefene Opioid Overdose | Phase 4 | 2023-06-01 |
| Completed | Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg Opioid Overdose | Phase 1 | 2022-10-03 |
| Terminated | Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children Attention Deficit/Hyperactivity Disorder | Phase 4 | 2021-08-03 |
| Terminated | Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit Attention-Deficit/Hyperactivity Disorder | Phase 4 | 2020-07-30 |
| Completed | Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health System Chronic Pain | — | 2017-10-05 |
| Completed | A Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the K Osteo Arthritis Knee | Phase 2 | 2017-03-14 |
| Withdrawn | Safety, Pharmacokinetics (PK), and Effectiveness of Hydrocodone Bitartrate (HYD) Extended-Release Tablets in C Pain | Phase 2 | 2017-01-01 |
| Terminated | A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Kn Osteoarthritis Pain of the Knee | Phase 2 | 2016-08-01 |
| Terminated | An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction Postsurgical Pain Due to Third Molar Extraction | Phase 2 | 2013-07-01 |
| Completed | The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subj Healthy | Phase 1 | 2012-11-01 |
| Completed | Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthriti Osteoarthritis, Knee, Pain | Phase 2 | 2012-09-01 |
| Completed | Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Postherpetic Neuralgia, Pain | Phase 2 | 2012-09-01 |
| Completed | The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/ ECG Effects | Phase 1 | 2012-03-01 |
| Withdrawn | Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Requir Other Acute Postoperative Pain, Prolonged Endotracheal Intubation | Phase 3 | 2011-11-01 |
| Completed | Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed O Pain | Phase 3 | 2011-10-01 |
| Completed | Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain Chronic Low Back Pain | Phase 3 | 2011-10-01 |
| Completed | Experimental Biomarker Study for Pain Thresholds Pain | Phase 1 | 2011-09-01 |
| Completed | Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Low Back Pain | Phase 3 | 2011-08-01 |
| Completed | A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Low Back Pain | Phase 3 | 2011-08-01 |
| Completed | Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignan Chronic Nonmalignant and Nonneuropathic Pain | Phase 3 | 2011-07-01 |
| Completed | Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children Pain | Phase 3 | 2011-07-01 |
| Completed | Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-exper Low Back Pain | Phase 3 | 2011-05-01 |
| Completed | Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe M Pain | Phase 3 | 2010-11-01 |
| Completed | Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients Opioid Analgesia | Phase 1 | 2010-07-01 |
| Completed | A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Faci Healthy | Phase 1 | 2008-07-01 |
| Completed | To Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities Healthy | Phase 1 | 2008-06-01 |
| Completed | Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee Chronic Pain, Osteoarthritis of the Knee | Phase 3 | 2007-09-01 |
| Completed | To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets Healthy | Phase 1 | 2007-08-01 |
| Completed | A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tabl Healthy | Phase 1 | 2007-08-01 |
| Completed | Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain Low Back Pain | Phase 3 | 2007-06-01 |
| Completed | An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain Postoperative Pain | Phase 4 | 2007-04-01 |
| Completed | To Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets Healthy | Phase 1 | 2007-02-01 |
| Completed | A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets Healthy Volunteers | Phase 1 | 2007-01-01 |
| Completed | A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tabl Healthy Volunteers | Phase 1 | 2007-01-01 |
| Completed | A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets Healthy Volunteers | Phase 1 | 2007-01-01 |
| Terminated | Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee R Postoperative Pain | Phase 2 | 2006-11-01 |
| Terminated | Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persi Chronic Non-Malignant Pain | Phase 3 | 2005-07-01 |
| Completed | The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Vo Healthy Volunteers | Phase 1 | 2004-07-01 |
| Terminated | Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 Back Pain Lower Back Chronic | Phase 3 | 2004-06-01 |
| Terminated | Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthri Osteoarthritis | Phase 3 | 2004-04-01 |
| Terminated | Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase Osteoarthritis | Phase 3 | 2004-04-01 |
| Terminated | Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pa Back Pain Lower Back Chronic | Phase 3 | 2004-02-01 |
| Terminated | Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Ph Osteoarthritis | Phase 3 | 2004-01-01 |
| Terminated | Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Saf Osteoarthritis | Phase 3 | 2003-12-01 |
| Completed | Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subject Osteoarthritis | Phase 3 | 2003-06-01 |
| Completed | Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Osteoarthritis | Phase 3 | 2003-04-01 |
| Completed | Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase Osteoarthritis | Phase 3 | 2003-04-01 |
| Completed | Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transderma Healthy | Phase 1 | 2002-10-01 |
| Completed | Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension S Chronic Nonmalignant Pain | Phase 3 | 2001-04-01 |
| Completed | Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain Chronic Non-malignant Pain | Phase 3 | 2001-03-01 |
| Completed | Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Stud Chronic Pain | Phase 3 | 2000-12-01 |
| Completed | Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BT Healthy | Phase 1 | 2000-11-01 |
| Completed | Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain. Osteoarthritis | Phase 3 | 1999-06-01 |
| Completed | The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain. Chronic Low Back Pain | Phase 3 | 1999-04-01 |
| Completed | The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain. Back Pain | Phase 3 | 1997-12-01 |
| Completed | The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pai Back Pain | Phase 3 | 1997-04-01 |
| Completed | The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain. Osteoarthritis | Phase 3 | 1996-11-01 |
| Completed | Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Postoperative Pain | Phase 2 | 1996-10-01 |